the delay is the rarity of the disease and the need for more information to develop the right endpoints for trials. best to be as informed as possible to accurately pinpoint all the effects of MSA on patients so that we can see how 434 affects function in all of these areas and thus measure the benefit to patients overall.
Ann: New Publication Demonstrates ATH434 is Neuroprotective, page-5
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(14.3%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $381 | 109K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 42 | 60011843 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 125715587 | 24 |
View Market Depth
| Last trade - 14.28pm 23/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |